SynuCa Therapeutics
PrivateLast Round
Follow-on Offering
Mar 2, 2026
Total Funding Raised
$2.01M
Company Overview
SynuCa Therapeutics is a drug discovery company that develops small molecule therapies intended to address Parkinson's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynuCa Therapeutics Comparables
Compare SynuCa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Teitur Trophics | 71% | |
| Mission Therapeutics | 70% | |
| Gain Therapeutics Inc | 69% | |
SynuCa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Mar 2, 2026 | ||||
| Accelerator | Feb 25, 2025 |
Key People
Founding team and executive leadership
SynuCa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Follow-on Offering, Accelerator |
| NOME | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$520K raised from BioInnovation Institute and NOME.
SynuCa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynuCa Therapeutics's valuation, stock price, and market status.